Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kaleido Biosciences, Inc. KLDO

Full chart Compare
Set alert

Price alert · KLDO

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.00001 52-week range 0.20005
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-15.61 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.1×
FY 2016: -33.1×FY 2017: -11.6×FY 2018: -6.8×FY 2019: -1.5×FY 2020: -3.7×FY 2021: -1.1×
FY 2016 5y median -3.7× FY 2021
P/S 90.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 312×FY 2021: 90.6×
FY 2016 5y median 0.0× FY 2021
P/B 9.4×
FY 2016: -18.9×FY 2017: -7.3×FY 2018: 7.2×FY 2019: 2.6×FY 2020: 14.9×FY 2021: 9.4×
FY 2016 5y median 7.2× FY 2021
P/FCF -1.3×
FY 2016: -33.4×FY 2017: -13.3×FY 2018: -8.5×FY 2019: -1.6×FY 2020: -4.6×FY 2021: -1.3×
FY 2016 5y median -4.6× FY 2021
EV/EBITDA -1.0×
FY 2016: -34.4×FY 2017: -11.4×FY 2018: -6.0×FY 2019: -0.9×FY 2020: -3.6×FY 2021: -1.0×
FY 2016 5y median -3.6× FY 2021
EV/Sales 75.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 286×FY 2021: 75.4×
FY 2016 5y median 0.0× FY 2021
FCF Yield -78.2%
FY 2016: -3.0%FY 2017: -7.5%FY 2018: -11.8%FY 2019: -61.5%FY 2020: -21.5%FY 2021: -78.2%
FY 2016 5y median -21.5% FY 2021

Profitability

Gross Margin -113.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -5640.2%FY 2021: -113.6%
FY 2016 5y median 0.0% FY 2021
Operating Margin -7940.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -8089.6%FY 2021: -7940.9%
FY 2016 5y median 0.0% FY 2021
Net Margin -8178.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -8371.3%FY 2021: -8178.3%
FY 2016 5y median 0.0% FY 2021
ROE -851.2%
FY 2016: 57.3%FY 2017: 63.1%FY 2018: -106.1%FY 2019: -173.9%FY 2020: -398.2%FY 2021: -851.2%
FY 2016 5y median -173.9% FY 2021
ROIC -239.5%
FY 2016: -249.6%FY 2017: -99.8%FY 2018: -81.8%FY 2019: -120.4%FY 2020: -164.9%FY 2021: -239.5%
FY 2016 5y median -120.4% FY 2021
ROA -180.1%
FY 2016: -194.1%FY 2017: -89.6%FY 2018: -72.4%FY 2019: -103.3%FY 2020: -137.5%FY 2021: -180.1%
FY 2016 5y median -103.3% FY 2021

Growth (YoY)

Revenue 13.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 13.2%
FY 2016 FY 2021
Operating Income -11.1%
FY 2016: 0.0%FY 2017: -186.5%FY 2018: -124.5%FY 2019: -42.8%FY 2020: 9.0%FY 2021: -11.1%
FY 2016 FY 2021
EPS (diluted) 11.5%
FY 2016: 0.0%FY 2017: -186.0%FY 2018: -70.7%FY 2019: -57.6%FY 2020: 26.3%FY 2021: 11.5%
FY 2016 FY 2021
Free Cash Flow -19.3%
FY 2016: 0.0%FY 2017: -150.4%FY 2018: -106.3%FY 2019: -61.0%FY 2020: 17.4%FY 2021: -19.3%
FY 2016 FY 2021

Financial Health

Current Ratio 1.4×
FY 2016: 3.6×FY 2017: 7.4×FY 2018: 6.7×FY 2019: 7.1×FY 2020: 2.9×FY 2021: 1.4×
FY 2016 5y median 6.7× FY 2021
Quick Ratio 1.4×
FY 2016: 3.6×FY 2017: 7.4×FY 2018: 6.7×FY 2019: 7.1×FY 2020: 2.9×FY 2021: 1.4×
FY 2016 5y median 6.7× FY 2021
Debt / Equity 2.0×
FY 2016: -0.3×FY 2017: -0.3×FY 2018: 0.3×FY 2019: 0.4×FY 2020: 1.0×FY 2021: 2.0×
FY 2016 5y median 0.4× FY 2021
Net Debt / EBITDA 0.2×
FY 2016: -0.2×FY 2017: 0.5×FY 2018: 1.0×FY 2019: 0.6×FY 2020: 0.3×FY 2021: 0.2×
FY 2016 5y median 0.5× FY 2021
Interest Coverage -30.9×
FY 2016: -66.9×FY 2017: -62.1×FY 2018: -60.4×FY 2019: -88.7×FY 2020: -28.1×FY 2021: -30.9×
FY 2016 5y median -60.4× FY 2021

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31